Xtant Medical Holdings, Inc. ( XTNT) - Key Metrics
XTNT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.16 | -$0.07 | -$0.05 | -$0.05 |
| 2026Q1 | $0.15 | -$0.02 | -$0.02 | -$0.02 |
| 2025Q4 | $0.23 | $0 | $0.04 | $0.04 |
| 2025Q3 | $0.24 | $0.01 | $0.03 | $0.03 |
| 2025Q2 | $0.25 | $0.03 | $0.01 | $0.01 |
XTNT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.50 |
| 2026Q1 | 0% | -6.31 |
| 2025Q4 | 0% | 490 |
| 2025Q3 | 0% | 17.26 |
| 2025Q2 | 0% | 7.25 |
XTNT
Price: $0.32
52 week price:
Earnings Per Share: -0.08 USD
Exchange: ASE
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 44500
Market Capitalization: 45.0 million